Target intelligence / Profile preview

Small Cajal body-specific RNA 16

Molecular classification: small nucleolar RNA, snoRNA, Cajal body-associated RNA, noncoding RNA

Overview

Small Cajal body-specific RNA 16 (also known as LOC124900529, ENSG00000252923) is a member of the small nucleolar RNA (snoRNA) family, specifically within the Cajal body-associated group. It is classified as a noncoding RNA, not a protein-coding gene. These RNAs typically function in the post-transcriptional modification of other small nuclear RNAs, particularly in the Cajal bodies of the nucleus. There is no evidence that this gene serves as a therapeutic target or has direct roles in disease, drug response, or established biomarker status in current databases[7].

Other names: LOC124900529ENSG00000252923

Biological functions

Putative role in RNA modificationRNA processing

Beyond the preview

Go deeper on Small Cajal body-specific RNA 16.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Cajal body-specific RNA 16.

Explore the full profile